Background: Viral load is the key indicator of the effectiveness of antiretroviral treatment in HIV patients. Study aimed to determine antiretroviral treatments failure rates and associated risk factors among HIV-infected adult patients in Congo. Methods: Data from the Congolese AIDS and Epidemics Control Council were combined to create a historical cohort. Patients were followed up between 2003 to 2017. Mixed logistic regression was used to identify treatment failure associated-factors. Intercooled Stata 10 (StataCorp LP, College Station, Texas, USA) software packages was used for analysis. Results: Over 14 years of follow-up, a total of 25,500 visits for 6391 adult patients were reported. Among them, 88% i.e. 22,328 visits (for a total of 6127 patients) were visits with treatment failure. In the multivariate analysis, being aged >26 years, having primary education level, being student, others nationality, unspecifiedmarital status and being worker in informal sector were found associated with a higher risk of treatment failure. Conversely, being pensioners, receiving second line therapeutic protocols and having good adherence to treatment were found significantly associated with a lower risk of treatment failure. Conclusion: Antiretroviral treatments failure among HIV-treated patients is common in Congo. Developing treatment adherence-centered interventions with focus in patients who have low socio-economic status needed to reduced treatments failure. As treatment failure is not only determined by individual factors, psychosocial supports and availability of antiretroviral drugs needs to be taken into account.
References
[1]
UNAIDS-AIDS Data 2019. https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf
[2]
Granich, R., et al. (2015) Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990-2013. PLoS ONE, 10, e0131353. https://doi.org/10.1371/journal.pone.0131353
[3]
Mocroft, A., et al. (2003) Decline in the AIDS and Death Rates in the EuroSIDA Study: An Observational Study. The Lancet (London, England), 362, 22-29. https://doi.org/10.1016/S0140-6736(03)13802-0
[4]
Meireles, M.V., Pascom, A.R.P. and Duarte, E.C. (2018) Factors Associated with Early Virological Response in HIV-Infected Individuals Starting Antiretroviral Therapy in Brazil (2014-2015): Results From a Large HIV Surveillance Cohort. Journal of Acquired Immune Deficiency Syndromes, 78, e19-e27. https://doi.org/10.1097/QAI.0000000000001684
[5]
Bulage, L., et al. (2017) Factors Associated with Virological Non-Suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015. BMC Infectious Diseases, 17, Article No. 326. https://doi.org/10.1186/s12879-017-2428-3
[6]
Ahoua, L., et al. (2009) Risk Factors for Virological Failure and Subtherapeutic Antiretroviral Drug Concentrations in HIV-Positive Adults Treated in Rural Northwestern Uganda. BMC Infectious Diseases, 9, Article No. 81. https://doi.org/10.1186/1471-2334-9-81
[7]
Hailu, G.G., Hagos, D.G., Hagos, A.K., Wasihun, A.G. and Dejene, T.A. (2018) Virological and Immunological Failure of HAART and Associated Risk Factors among Adults and Adolescents in the Tigray Region of Northern Ethiopia. PLoS ONE, 13, e0196259. https://doi.org/10.1371/journal.pone.0196259
[8]
Biset Ayalew, M., et al. (2016) First-Line Antiretroviral Treatment Failure and Associated Factors in HIV Patients at University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia. HIV/AIDS—Research and Palliative Care, 8, 141-146. https://doi.org/10.2147/HIV.S112048
[9]
Wang, J., et al. (2014) Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011-2012. PLoS ONE, 9, e88305. https://doi.org/10.1371/journal.pone.0088305
[10]
Tuboi, S.H., Harrison, L.H., Sprinz, E., Albernaz, R.K.M. and Schechter, M. (2005) Predictors of Virologic Failure in HIV-1-Infected Patients Starting Highly Active Antiretroviral Therapy in Porto Alegre, Brazil. JAIDS Journal of Acquired Immune Deficiency Syndromes, 40, 324-328. https://doi.org/10.1097/01.qai.0000182627.28595.01
[11]
Le Moing, V., et al. (2001) Clinical, Biologic, and Behavioral Predictors of Early Immunologic and Virologic Response in HIV-Infected Patients Initiating Protease Inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes, 27, 372-376. https://doi.org/10.1097/00126334-200108010-00007
[12]
En finir avec le sida—Progresser vers les cibles 90-90-90—Synthèse—Recherche Google. https://www.google.com/search?client=firefox-b-d&q=En+finir+avec+le+sida++Progresser
+vers+les+cibles+90-90-90+-+Synth%C3%A8se
[13]
Ndziessi, G., et al. (2013) Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial). PLoS ONE, 8, e62611. https://doi.org/10.1371/journal.pone.0062611
[14]
CNSEE, CNLS, ICF MACRO (2009) Congo, Rep. Enquête de Séroprévalence et sur les Indicateurs du Sida du Congo. https://microdata.worldbank.org/index.php/catalog/2848
[15]
Dokekias, A.E., et al. (2008) Evaluation du traitement antirétroviral chez les adultes infectés par le VIH, suivis dans le service d’hématologie du CHU de Brazzaville, Congo. Bulletin de la Société de Pathologie Exotique, 101, 109-112.
[16]
Faure, N., Diafouka, M., Nzounza, P., Ekat, M., Mahambou Nsonde, D., Levaseur, G., et al. (2011) Observance thérapeutique des personnes vivant avec le VIH en 2009 au centre de traitement ambulatoire de Brazzaville, Congo. Médecine Tropicale, 71, 487-491.
[17]
Moosa, A., Gengiah, T.N., Lewis, L. and Naidoo, K. (2019) Long-Term Adherence to Antiretroviral Therapy in a South African Adult Patient Cohort: A Retrospective Study. BMC Infectious Diseases, 19, Article No. 775. https://doi.org/10.1186/s12879-019-4410-8
[18]
Paterson, D.L., et al. (2000) Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection. Annals of Internal Medicine, 133, 21-30.
[19]
Bvochora, T., et al. (2019) Enhanced Adherence Counselling and Viral Load Suppression in HIV Seropositive Patients with an Initial High Viral Load in Harare, Zimbabwe: Operational Issues. PLoS ONE, 14, e0211326. https://doi.org/10.1371/journal.pone.0211326
[20]
Glass, T.R., et al. (2019) The Viral Load Monitoring Cascade in a Resource-Limited Setting: A Prospective Multicentre Cohort Study after Introduction of Routine Viral Load Monitoring in Rural Lesotho. PLoS ONE, 14, e0220337. https://doi.org/10.1371/journal.pone.0220337
[21]
Nicholas, S., et al. (2019) Point-of-Care Viral Load Monitoring: Outcomes from a Decentralized HIV Programme in Malawi. Journal of the International AIDS Society, 22, e25387. https://doi.org/10.1002/jia2.25387
[22]
Mbengue, M.A.S., Sarr, S.O., Diop, A., Ndour, C.T., Ndiaye, B. and Mboup, S. (2019) Prevalence and Determinants of Adherence to Antiretroviral Treatment among HIV Patients on First-Line Regimen: A Cross-Sectional Study in Dakar, Senegal. The Pan African Medical Journal, 33, 95. https://doi.org/10.11604/pamj.2019.33.95.17248
[23]
Ordóñez, C.E. and Marconi, V.C. (2012) Understanding HIV Risk Behavior from a Sociocultural Perspective. Journal of AIDS & Clinical Research, 3, e108. https://doi.org/10.4172/2155-6113.1000e108
[24]
Cao, P., et al. (2018) Treatment Outcomes and HIV Drug Resistance of Patients Switching to Second-Line Regimens after Long-Term First-Line Antiretroviral Therapy: An Observational Cohort Study. Medicine (Baltimore), 97, e11463. https://doi.org/10.1097/MD.0000000000011463
[25]
Cohen, M.S., et al. (2011) Prevention of HIV-1 Infection with Early Antiretroviral Therapy. The New England Journal of Medicine, 365, 493-505. https://doi.org/10.1056/NEJMc1110588
[26]
Cohen, M.S., et al. (2016) Antiretroviral Therapy for the Prevention of HIV-1 Transmission. The New England Journal of Medicine, 375, 830-839.
[27]
Beltrán, M.A., Gil, R.A. and Nasiff, V. (2018) Non-Compliance with Antiretroviral Treatment and Undetectable HIV Viral Load. Medicina (Mex.), 78, 378-379.
[28]
Silveira, M.P.T., Maurer, P., Guttier, M.C. and Moreira, L.B. (2015) Factors Associated with Therapeutic Success in HIV-Positive Individuals in Southern Brazil. Journal of Clinical Pharmacy and Therapeutics, 40, 192-195. https://doi.org/10.1111/jcpt.12233
[29]
Cambiano, V., et al. (2010) Use of a Prescription-Based Measure of Antiretroviral Therapy Adherence to Predict Viral Rebound in HIV-Infected Individuals with Viral Suppression. HIV Medicine, 11, 216-224. https://doi.org/10.1111/j.1468-1293.2009.00771.x
[30]
Ingle, S., et al. (2018) Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration. Journal of Clinical Medicine, 7, 328. https://doi.org/10.3390/jcm7100328
[31]
ONUSIDA. En finir avec le sida—Progresser vers les cibles 90-90-90—Synthèse. https://www.unaids.org/fr/resources/documents/2017/20170720_Global_AIDS_update_2017
[32]
Kaishusha Mupendwa, B.-P. and Kadima Ntokamunda, J.-L. (2009) Treatment Adhesion and Factors Affecting It at the Kadutu Clinic (Democratic Republic of the Congo). Sante (Montrouge, France), 19, 205-215. https://doi.org/10.1684/san.2009.0178
[33]
Chop, E., et al. (2017) Food Insecurity, Sexual Risk Behavior, and Adherence to Antiretroviral Therapy among Women Living with HIV: A Systematic Review. Health Care for Women International, 38, 927-944. https://doi.org/10.1080/07399332.2017.1337774
[34]
Ndziessi, G., et al. (2012) Adherence as a Predictor of Sexual Behaviors in People Living with HIV/AIDS during the First Year of Antiretroviral Therapy in Rural Cameroon: Data from Stratall ANRS 12110/ESTHER Trial. PLoS ONE, 7, e36118. https://doi.org/10.1371/journal.pone.0036118
[35]
Baltazary, G., Akarro, R.R.J. and Mussa, A.S. (2011) Some Factors Associated with Non-Adherence to Antiretroviral Therapy (ART) in People Living with HIV/AIDS (PLHA) in Tanzania: A Case Study of Dar es Salaam Region. East African Journal of Public Health, 8, 237-246.
[36]
Filimão, D.B.C., Moon, T.D., Senise, J.F., Diaz, R.S., Sidat, M. and Castelo, A. (2019) Individual Factors Associated with Time to Non-Adherence to ART Pick-Up within HIV Care and Treatment Services in Three Health Facilities of Zambézia Province, Mozambique. PLoS ONE, 14, e0213804. https://doi.org/10.1371/journal.pone.0213804
[37]
Letta, S., Demissie, A., Oljira, L. and Dessie, Y. (2015) Factors Associated with Adherence to Antiretroviral Therapy (ART) among Adult People Living with HIV and Attending Their Clinical Care, Eastern Ethiopia. BMC International Health and Human Rights, 15, 33. https://doi.org/10.1186/s12914-015-0071-x
[38]
Tarekegn, M., Baru, A. and Seme, A. (2019) Levels of Option B+ ART Drugs Adherence and Associated Factors among Pregnant Women Following ART Services at Public Health Facilities of East Shawa Zone, Oromia, Ethiopia. Sexual & Reproductive Healthcare, 22, Article ID: 100459. https://doi.org/10.1016/j.srhc.2019.100459
[39]
Ntela, S.-D.M., et al. (2018) Observance to Antiretroviral Treatment in the Rural Region of the Democratic Republic of Congo: A Cognitive Dissonance. The Pan African Medical Journal, 31, 159. https://doi.org/10.11604/pamj.2018.31.159.15132
[40]
Mbuagbaw, L., et al. (2012) Trends and Determining Factors Associated with Adherence to Antiretroviral Therapy (ART) in Cameroon: A Systematic Review and Analysis of the CAMPS Trial. AIDS Research and Therapy, 9, 37.
https://doi.org/10.1186/1742-6405-9-37
[41]
Bastard, M., Fall, M.B.K. and Groupe d’étude de la Cohorte ANRS 1215 (2014) Observance à long terme au traitement antirétroviral au Sénégal. Bulletin de la Société de Pathologie Exotique, 107, 241-243. https://doi.org/10.1007/s13149-014-0346-9
